StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Acro Biomedical's profit margin for the twelve months ending Sep 30, 2023 was -3534.4%. For fiscal 2022 it was -2410.2%, against -642.8% the year before. The highest annual figure on record is 5.2% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-2410.2%−1767.4
FY2021Dec 31, 2021-642.8%−615.4
FY2019Sep 30, 2019-27.4%−32.6
FY2018Sep 30, 20185.2%+5.7
FY2017Sep 30, 2017-0.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ4 2022Dec 31, 2022-1093.0%−1033.2
Q1 FY2022CQ1 2022Mar 31, 2022-1316.2%−1310.6
Q4 FY2021CQ4 2021Dec 31, 2021-644.3%−650.7
Q2 FY2021CQ2 2021Jun 30, 2021-158.9%−164.2
Q1 FY2021CQ1 2021Mar 31, 2021-59.8%−63.3
Q1 FY2019CQ4 2018Dec 31, 2018-5.5%−11.1
Q4 FY2018CQ3 2018Sep 30, 20186.4%–
Q3 FY2018CQ2 2018Jun 30, 20185.3%–
Q2 FY2018CQ1 2018Mar 31, 20183.5%–
Q1 FY2018CQ4 2017Dec 31, 20175.6%–

More Acro Biomedical figures

See a number that looks wrong?